Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial

NCT04188639 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT04188639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial
Lead sponsor
GWT-TUD GmbH
Phase
Phase 2
Overall status
Completed
Start date
March 23, 2021
Completion date
January 4, 2023
Enrollment
47 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a, acquired